KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2026028631-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Tremblay Frederic patents
Tremblay Frederic is listed as an inventor on 23 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tremblay Frederic |
| Total patents | 23 |
| First publication | Oct 1, 2020 |
| Latest publication | Jan 29, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
US-12522822-B2 · Jan 13, 2026 · US
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
US-12480125-B2 · Nov 25, 2025 · US
17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025333737-A1 · Oct 30, 2025 · US
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
US-12404508-B2 · Sep 2, 2025 · US
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-12359201-B2 · Jul 15, 2025 · US
High mobility group box-1 (hmgb1) irna compositions and methods of use thereof
US-2025188456-A1 · Jun 12, 2025 · US
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2024150769-A1 · May 9, 2024 · US
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
US-11926832-B2 · Mar 12, 2024 · US
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023416748-A1 · Dec 28, 2023 · US
Recent patents
Latest publications not already listed above.
KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023323363-A1 · Oct 12, 2023 · US
G protein-coupled receptor 146 (gpr146) irna compositions and methods of use thereof
US-2023287432-A1 · Sep 14, 2023 · US
Compositions and methods for silencing dnajc15 gene expression
US-2023190785-A1 · Jun 22, 2023 · US
Compositions and methods for inhibiting marc1 gene expression
US-2023183707-A1 · Jun 15, 2023 · US
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2022348926-A1 · Nov 3, 2022 · US
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2022042014-A1 · Feb 10, 2022 · US
17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
US-2021380985-A1 · Dec 9, 2021 · US
17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-11180757-B1 · Nov 23, 2021 · US
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
US-11162103-B2 · Nov 2, 2021 · US
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
US-11149276-B2 · Oct 19, 2021 · US
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021292756-A1 · Sep 23, 2021 · US
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2021189400-A1 · Jun 24, 2021 · US
High mobility group box-1 (hmgb1) irna compositions and methods of use thereof
US-2020308588-A1 · Oct 1, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Alnylam Pharmaceuticals Inc | 19 |
| Regeneron Pharma | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/14 | 22 |
| A61K31/713 | 21 |
| C12N2310/315 | 21 |
| C12N2310/321 | 19 |
| C12N2310/322 | 19 |